A Study of 177Lu-PSMA-617 in People With Gliomas — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York Last updated November 2025